Sign in
4

Changes in Ownership

Adaptive Biotechnologies Corp Filed Acc 0001209191-21-028051

Chief Scientific Officer sold 27,265 shares at an average $41.56 ($1,133,212)

  • Chief Scientific Officer acquired 27,265 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

ROBINS HARLAN S · Chief Scientific Officer

Table I: Non-derivative

10 lines
Date Transaction Shares Price Value Owned after D/I
2021-04-20 Exercise or conversion : show line 1 in the form +11,685 $6.32 $73,849 81,045 D
2021-04-20 Sale : show line 2 in the form −8,685 $40.24 $349,484 72,360 D
2021-04-20 Sale : show line 3 in the form −3,000 $41.35 $124,050 69,360 D
2021-04-21 Exercise or conversion : show line 4 in the form +7,790 $6.32 $49,233 77,150 D
2021-04-21 Sale : show line 5 in the form −500 $39.85 $19,925 76,650 D
2021-04-21 Sale : show line 6 in the form −2,090 $41.17 $86,045 74,560 D
2021-04-21 Sale : show line 7 in the form −5,200 $41.79 $217,308 69,360 D
2021-04-22 Exercise or conversion : show line 8 in the form +7,790 $6.32 $49,233 77,150 D
2021-04-22 Sale : show line 9 in the form −4,280 $42.85 $183,398 72,870 D
2021-04-22 Sale : show line 10 in the form −3,510 $43.59 $153,001 69,360 D
Open-market sales · 27,265 sh · avg $41.56 · $1,133,212

Table II: Derivative

3 lines
Date Transaction Shares Owned after D/I
2021-04-20 Exercise or conversion : show line 11 in the form Stock Option (Right to Buy) −11,685 155,800 D
2021-04-21 Exercise or conversion : show line 12 in the form Stock Option (Right to Buy) −7,790 148,010 D
2021-04-22 Exercise or conversion : show line 13 in the form Stock Option (Right to Buy) −7,790 140,220 D
Loading xslF345X03/doc4.xml…